Ted C K Lee

Title: Innovations in Hemostasis: The Contributions of Inventor Ted C K Lee

Introduction

Ted C K Lee, located in Matawan, NJ, is a notable inventor recognized for his work in the field of biomedical innovations. He holds four patents to his name, showcasing his commitment to enhancing healthcare solutions. His latest patents focus on the development of a prothrombin time reagent for the determination of low molecular weight heparin, which has significant implications in medical diagnostics.

Latest Patents

Ted's most recent patent involves an assay for low molecular weight heparin designed for use in fresh whole blood and anticoagulant-treated blood. The reagent is composed of recombinant animal tissue factor and a mixture of synthetic phospholipids, including a specific phosphatidylalcohol. The formulation buffer uses a sensitivity adjuster, notably γ-Cyclodextrin, ensuring the formulation remains stable for at least three weeks at 37°C. This innovative reagent supports accurate measurements essential for patient care and safety during anticoagulation therapies.

Career Highlights

Ted C K Lee has made significant contributions to the field of medical technology through his role at International Technidyne Corporation. His work focuses on innovative solutions that address pressing challenges in hemostasis and blood diagnostics.

Collaborations

Throughout his career, Ted has collaborated with esteemed colleagues, including Amanda B McBride and Frank M LaDuca. Their collective expertise and effort have enhanced the development of medical devices and reagents, pushing the boundaries of what is achievable in the healthcare sector.

Conclusion

With a foundation built on innovation and collaboration, Ted C K Lee continues to contribute to medical advancements that improve patient outcomes. His patents are a testament to the essential role of inventors in shaping the future of healthcare technology.